Aibotics Inc. logo

Aibotics Inc. (AIBT)

Market Closed
12 Aug, 16:13
OTC PINK OTC PINK
$
0. 00
0
0%
$
220.31K Market Cap
- P/E Ratio
- Div Yield
150,000 Volume
- Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0.01
Want to track AIBT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AIBT closed today higher at $0, an increase of 0% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, AIBT stock lost -86.6667%.
AIBT is not paying dividends to its shareholders.
Aibotics Inc. has completed 1 stock splits, with the recent split occurring on May 01, 2014.
The company's stock is traded on one exchange.

AIBT Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.38
-1.8088%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

Aibotics Inc. (AIBT) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Aibotics Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is AIBT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 220.31K.

Has Aibotics Inc. ever had a stock split?

Aibotics Inc. had 1 splits and the recent split was on May 01, 2014.

Aibotics Inc. Profile

Biotechnology Industry
Healthcare Sector
Benjamin Kaplan CEO
OTC PINK Exchange
62846W107 CUSIP
US Country
1 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Aibotics Inc., along with its subsidiaries, focuses on the exploration and study of psychedelics aimed at treating various mental health disorders in the United States. This innovative company specializes in the development of psychedelic methodologies targeted towards alleviating conditions such as palliative care challenges, depression, and anxiety. Originally known as Mycotopia Therapies, Inc., the company rebranded to Aibotics Inc. in February 2025. The corporate headquarters are located in Miami, Florida, propelling Aibotics as a vital entity in the burgeoning field of psychedelic therapy.

Products and Services

  • Psychedelic Therapies for Depression

    Aibotics Inc. offers comprehensive treatment methodologies designed to utilize psychedelics in addressing major depressive disorders. These innovative therapies aim to provide patients with sustainable relief, harnessing the unique properties of psychedelics to facilitate profound psychological healing.

  • Anxiety Reduction Programs

    The company develops and implements specialized programs focusing on the use of psychedelics as therapeutic agents to reduce anxiety symptoms. Aibotics employs evidence-based practices to ensure that their methodologies yield effective outcomes for individuals struggling with anxiety-related disorders.

  • Palliative Care Solutions

    Aibotics innovates treatments that integrate psychedelic experiences into palliative care, providing comfort and emotional support to patients facing terminal illnesses. The aim is to enhance the quality of life and alleviate psychological distress for both patients and their families.

  • Research and Development Services

    The company actively engages in research programs aimed at understanding the therapeutic potential of various psychedelics. By collaborating with academic institutions and health organizations, Aibotics contributes to the growing body of knowledge surrounding psychedelic applications in mental health.

  • Patient Support Programs

    Aibotics recognizes the importance of supporting patients through their therapeutic journey. They provide access to counseling and recovery resources tailored to individual needs, ensuring that each patient benefits fully from psychedelic treatments while maintaining safety and efficacy.

Contact Information

Address: 100 SE 2nd Street
Phone: 954 233 3511